Review
Open access
Sep 2026
Ibalizumab: a comprehensive review of a pioneering monoclonal antibody therapy in the management of HIV/AIDS
Of the approximately 40 million people living with human immunodeficiency virus (HIV) globally as of 2022, a clinically significant subset harbours multidrug-resistant (MDR) HIV-1, leaving them with few viable antiretroviral options. Ibalizumab (Trogarzo), a recombinant humanised IgG4 monoclonal antibody, received FDA...
P. Ashinze, Suvam Banerjee, E. Akande et al.
· Exploration of Medicine · 0 citations